They discovered that the delivery of FADD mediated by TAT in colon cancer HCT116 cells significantly suppressed the canonical NLRP3 inflammasome priming by downregulating NLRP3, thereby restricting the processing and secretion of proinflammatory IL-1β. The gene discussed is NLRP3; the disease is colonic neoplasm.